Related references
Note: Only part of the references are listed.MAFLD: Renovation of clinical practice and disease awareness of fatty liver
Takumi Kawaguchi et al.
HEPATOLOGY RESEARCH (2022)
Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade
Herbert Tilg et al.
HEPATOLOGY (2021)
Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD
Vy H. Nguyen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan
Hirayuki Enomoto et al.
JOURNAL OF GASTROENTEROLOGY (2021)
MAFLD and risk of CKD
Dan-Qin Sun et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease
Jiaofeng Huang et al.
RISK MANAGEMENT AND HEALTHCARE POLICY (2021)
MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach
Tsubasa Tsutsumi et al.
HEPATOLOGY RESEARCH (2021)
Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study
Shuhei Fukunaga et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease
Fasiha Kanwal et al.
HEPATOLOGY (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Complications, morbidity and mortality of nonalcoholic fatty liver disease
Alessandro Mantovani et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis
Bjorn Carlsson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
Ze Chen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
Jiezhong Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
Hideki Fujii et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Concordance between MAFLD and NAFLD diagnostic criteria in 'real-world' data
Giovanni Targher
LIVER INTERNATIONAL (2020)
Comparison of MAFLD and NAFLD diagnostic criteria in real world
Su Lin et al.
LIVER INTERNATIONAL (2020)
Genetic and epigenetic factors determining NAFLD risk
Wenke Jonas et al.
MOLECULAR METABOLISM (2020)
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Zobair Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Zobair Younossi et al.
HEPATOLOGY (2019)
The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study
Alina M. Allen et al.
JOURNAL OF HEPATOLOGY (2019)
The role of the microbiome in NAFLD and NASH
Aleksandra A. Kolodziejczyk et al.
EMBO MOLECULAR MEDICINE (2019)
Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease
Reenam S. Khan et al.
HEPATOLOGY (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma
Tomi W. Jun et al.
LIVER INTERNATIONAL (2018)
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes et al.
JOURNAL OF HEPATOLOGY (2018)
Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
Leon A. Adams et al.
GUT (2017)
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Anna M. Diehl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease
Alessandro Mantovani et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Time to Abandon NASH?
Jean-Francois Dufour
HEPATOLOGY (2016)
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
Andrea Marengo et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
Genetic background in nonalcoholic fatty liver disease: A comprehensive review
Fabio Salvatore Macaluso et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis
Amit G. Singal et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease
Giuseppe Paradies et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population
Maria Stepanova et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Nonalcoholic steatohepatitis and increased risk of chronic kidney disease
Kohichiroh Yasui et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Increased Risk of CKD among Type 2 Diabetics with Nonalcoholic Fatty Liver Disease
Giovanni Targher et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients
Giovanni Targher et al.
DIABETES CARE (2007)
Should nonalcoholic fatty liver disease be renamed?
P Loria et al.
DIGESTIVE DISEASES (2005)
Share Paper
